This study examined the relationship between the Monetary Policy Rate (MPR) and inflation across five continents from 2014 to 2023 using both Frequentist and Bayesian Linear Mixed Models (LMM). It ...

The grocery store formerly known as Steve’s 9th Street Supermarket in Park Slope has a new occupant. K Slope Market, a full-service supermarket and member of the Key Food Cooperative, opened its doors ...

After half a decade of stagnant grids without any major team changes, Formula 1 is about to get two big new automakers at once. One is Cadillac, the American entrant building a new team from the ...

Once again, Israeli bombs rained down on Gaza. The latest wave of strikes killed more than 100 people, mostly women and children, according to health authorities. The bombardment marked the deadliest ...

The Intercept dropped its most significant story in its three-year history on Tuesday. The website published a piece based on leaked NSA documents that detailed what appeared to be a previously ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

A federal judge in San Francisco on Wednesday temporarily blocked a federal administrative subpoena aimed at unmasking Instagram accounts that named and shamed a Border Patrol agent who was part of ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...